Honestly led, I think all that matters is that BOM reaches a RRR of 30% or better. The name of the trial says it all. BETonMACE. And there are plenty of drugs that are being advertised pushing MACE reduction on commercial TV these days emphasizing the importance in this regard. 

The finance is not much of an issue as it seems for Resverlogix because DM always looked after it in more ways than one. And I highly doubt HL will let Resverlogix default on the Third Eye loan. It's too small of a loan. What's left on it, $15K-$20K? Paying off a little loan won't mean much to the SP.

Moving the goal posts on the trial results is not helping much. But it is what it is. We just need to be practical and patient at the same time for just a little bit longer than we hoped. 

Them's the breaks as they say. Like it or lump it. It's out of our hands.    

IMO...Koo